Cesca Therapeutics Stock Quote KOOL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

5.14

Bid

3.30

Ask

5.22

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

16.124M

Previous Close

5.14

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

3,137,000

Dividend Yield

PE Ratio

-0.90

Earnings Per Share (EPS)

-5.73

Revenue

9.45M

Net Profit

-17.98M

Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, Therm... Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca's clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets. Show more

Sector

Lab Apparatus And Furniture

Industry

Lab Apparatus And Furniture

Website

www.thermogenesis.com

Headquarters

Wilmington, Delaware, USA

Founded

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus ThermoGenesis to Focus on Developing Automated Cell Processing Tools and Services for the Cell and Gene Therapy...

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference PR Newswire RANCHO CORDOVA, Calif., Oct. 24, 2019 RANCHO CORDOVA, Calif., Oct. 24, 2019...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services ImmuneCyte to Begin Operations in Fourth Quarter of 2019 PR...

Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...

Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13 PR Newswire RANCHO CORDOVA, Calif., Aug. 6, 2019 RANCHO...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HTOOFusion Fuel Green PLC	$ 0.7584 (138.49%)	16.74M
HRTXHeron Therapeautics Inc	$ 2.26 (91.53%)	8.44M
VIRXViracta Therapeutics Inc	$ 0.2123 (30.41%)	6.61M
OKTAOkta Inc	$ 93.80 (14.80%)	3.21M
ALTAltimmune Inc	$ 10.09 (14.79%)	289.76k
ORISOriental Rise Holdings Ltd	$ 6.93 (-42.01%)	348.55k
TRVITrevi Therapeutics Inc	$ 2.1301 (-23.38%)	138.33k
NOTVInotiv Inc	$ 3.44 (-17.90%)	64.31k
MDBHMDB Capital Holdings LLC	$ 5.9844 (-13.89%)	100
LUNRIntuitive Machines Inc	$ 12.22 (-13.64%)	4.37M
HTOOFusion Fuel Green PLC	$ 0.7584 (138.49%)	16.74M
HRTXHeron Therapeautics Inc	$ 2.26 (91.53%)	8.44M
VIRXViracta Therapeutics Inc	$ 0.2123 (30.41%)	6.61M
NVDANVIDIA Corporation	$ 140.47 (0.15%)	6.22M
LUNRIntuitive Machines Inc	$ 12.22 (-13.64%)	4.37M